Analysts Set LivaNova PLC (NASDAQ:LIVN) PT at $69.38

Shares of LivaNova PLC (NASDAQ:LIVN) have earned a consensus rating of “Moderate Buy” from the nine analysts that are covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $69.3750.

Several equities analysts have recently issued reports on the stock. Stifel Nicolaus upped their price objective on shares of LivaNova from $65.00 to $70.00 and gave the company a “buy” rating in a report on Wednesday, January 7th. KeyCorp assumed coverage on shares of LivaNova in a research report on Friday, December 19th. They set an “overweight” rating and a $81.00 target price on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of LivaNova in a research note on Monday, December 29th. The Goldman Sachs Group reiterated a “neutral” rating and set a $66.00 price objective on shares of LivaNova in a research note on Friday, January 9th. Finally, Robert W. Baird set a $75.00 price objective on shares of LivaNova in a report on Tuesday, December 16th.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Arizona State Retirement System boosted its position in LivaNova by 1.7% in the third quarter. Arizona State Retirement System now owns 16,129 shares of the company’s stock valued at $845,000 after buying an additional 274 shares during the last quarter. Bayforest Capital Ltd raised its position in LivaNova by 44.8% during the 3rd quarter. Bayforest Capital Ltd now owns 918 shares of the company’s stock worth $48,000 after buying an additional 284 shares during the last quarter. State of Michigan Retirement System lifted its stake in LivaNova by 2.3% during the 2nd quarter. State of Michigan Retirement System now owns 13,111 shares of the company’s stock valued at $590,000 after acquiring an additional 300 shares during the period. UMB Bank n.a. lifted its stake in LivaNova by 63.0% during the 3rd quarter. UMB Bank n.a. now owns 792 shares of the company’s stock valued at $41,000 after acquiring an additional 306 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of LivaNova by 182.5% in the 2nd quarter. GAMMA Investing LLC now owns 630 shares of the company’s stock valued at $28,000 after acquiring an additional 407 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

LivaNova Stock Performance

Shares of LIVN opened at $65.93 on Friday. The company has a current ratio of 1.33, a quick ratio of 1.12 and a debt-to-equity ratio of 0.30. The firm has a market cap of $3.60 billion, a PE ratio of -16.48 and a beta of 0.97. LivaNova has a 12 month low of $32.48 and a 12 month high of $67.92. The stock has a fifty day moving average price of $63.27 and a 200-day moving average price of $56.35.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.